[Fundamental and clinical studies of aztreonam in the field of pediatric].

Author: ChikaokaH, KamigakiM, KoidoR, MatsumotoK, NakadaY, NakazawaS, NaritaA, SatoH, SuzukiH

Paper Details 
Original Abstract of the Article :
The fundamental and clinical studies of aztreonam (AZT) were performed. The results were as follows: The MICs of AZT for E. coli and Salmonella sp. which were recently isolated in the pediatric field were less than 0.78 micrograms/ml. AZT also was effective against ABPC/PIPC-resistant bacteria. The ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/4094057

データ提供:米国国立医学図書館(NLM)

Aztreonam: A New Weapon in the Desert of Pediatric Infections

Pediatric infections can be a daunting challenge, like a sandstorm sweeping across a vulnerable landscape. This study explores the potential of aztreonam, a type of antibiotic, as a new weapon against these infections. The researchers delved into the effectiveness of aztreonam against various bacteria, its pharmacokinetic properties, and its safety in children.

Targeting the Enemy: Effective Treatment for Pediatric Infections

The study revealed that aztreonam was effective against a wide range of bacteria, including those resistant to other antibiotics. It's like having a highly accurate arrow in the quiver of a skilled archer, targeting specific bacteria and disabling their harmful effects. This suggests that aztreonam could provide a valuable tool in the fight against pediatric infections, especially those resistant to more conventional therapies.

A Promising Oasis in the Desert of Pediatric Care

The study's findings provide a hopeful oasis in the desert of pediatric care. Aztreonam demonstrated good efficacy and safety in treating children with a variety of infections. However, it's important to note that further research is needed to understand the long-term effects of this drug on children. As always, caution is essential when navigating this complex landscape.

Dr. Camel's Conclusion

This research explores aztreonam as a promising treatment option for pediatric infections. The study suggests that aztreonam could offer a much-needed oasis in the desert of pediatric care, but further research is necessary to ensure its long-term safety and efficacy.

Date :
  1. Date Completed 1986-04-21
  2. Date Revised 2016-11-16
Further Info :

Pubmed ID

4094057

DOI: Digital Object Identifier

4094057

Related Literature

SNS
PICO Info
in preparation
Languages

Japanese

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.